Jenn-Yeu ShinChen-Yu WangChi-Chien LinCHING-LIANG CHU2021-02-042021-02-0420201672-76812042-0226https://scholars.lib.ntu.edu.tw/handle/123456789/547697[SDGs]SDG3CD103 antigen; CD11b antigen; CD4 antigen; CD8 antigen; Article; CD103- CD11b+ type 2 conventional dendritic cell; CD4+ T lymphocyte; CD8+ T lymphocyte; cell differentiation; cell engineering; cell function; cell maturation; cell subpopulation; cell therapy; cellular immunity; dendritic cell; human; immunoregulation; immunotherapy; inflammatory disease; mesenchymal stroma cell; monocyte; nonhuman; ontogeny; type 2 conventional dendritic cell; upregulation; dendritic cell; inflammation; macrophage; non insulin dependent diabetes mellitus; virus infection; Dendritic Cells; Diabetes Mellitus, Type 2; Humans; Inflammation; Macrophages; Virus Diseasesjournal article10.1038/s41423-020-0511-y327329882-s2.0-85088784208WOS:000554055000001https://doi.org/10.1038/s41423-020-0511-y78091828